Ngā hua rapu - Steven M. Offer
- E whakaatu ana i te 1 - 14 hua o te 14
-
1
-
2
-
3
Phenotypic Profiling of <i>DPYD</i> Variations Relevant to 5-Fluorouracil Sensitivity Using Real-time Cellular Analysis and <i>In Vitro</i> Measurement of Enzyme Activity mā Steven M. Offer, Natalie J. Wegner, Croix C. Fossum, Kangsheng Wang, Robert B. Diasio
I whakaputaina 2013Artigo -
4
-
5
-
6
-
7
Comparative Functional Analysis of <i>DPYD</i> Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity mā Steven M. Offer, Croix C. Fossum, Natalie J. Wegner, Alexander J. Stuflesser, Gabriel L. Butterfield, Robert B. Diasio
I whakaputaina 2014Artigo -
8
microRNAs miR-27a and miR-27b Directly Regulate Liver Dihydropyrimidine Dehydrogenase Expression through Two Conserved Binding Sites mā Steven M. Offer, Gabriel L. Butterfield, Calvin R. Jerde, Croix C. Fossum, Natalie J. Wegner, Robert B. Diasio
I whakaputaina 2014Artigo -
9
Updated <i>DPYD</i><scp>HapB3</scp> haplotype structure and implications for pharmacogenomic testing mā Amy Turner, Cyrine E. Haidar, Wenjian Yang, Erin C. Boone, Steven M. Offer, Philip E. Empey, Andrew Haddad, Saba Tahir, Gunter Scharer, Ulrich Broeckel, Andrea Gaedigk
I whakaputaina 2023Artigo -
10
Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency mā Qiang Pan‐Hammarström, Ulrich Salzer, Likun Du, Janne Björkander, Charlotte Cunningham‐Rundles, David L. Nelson, Chiara Bacchelli, H. Bobby Gaspar, Steven M. Offer, Timothy W. Behrens, Bodo Grimbacher, Lennart Hammarström
I whakaputaina 2007Carta -
11
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update mā Ursula Amstutz, Linda M. Henricks, Steven M. Offer, Julia M. Barbarino, Jan H.M. Schellens, Jesse J. Swen, Teri E. Klein, Howard L. McLeod, Kelly E. Caudle, Robert B. Diasio, Matthias Schwab
I whakaputaina 2017Revisão -
12
Symmetric inheritance of parental histones contributes to safeguarding the fate of mouse embryonic stem cells during differentiation mā Qing Wen, Jiaqi Zhou, Congcong Tian, Xinran Li, Guibing Song, Yuan Gao, Yaping Sun, Chiyuan Ma, Sitong Yao, Xiaoyan Liang, Xing Kang, Nan Wang, Yuan Yao, Hongbao Wang, Xiao‐Huan Liang, Jialin Tang, Steven M. Offer, Xiaohua Lei, Chuanhe Yu, Xiangyu Liu, Zichuan Liu, Zhiquan Wang, Haiyun Gan
I whakaputaina 2023Artigo -
13
A phosphotyrosine switch regulates organic cation transporters mā Jason A. Sprowl, Su Sien Ong, Alice A. Gibson, Shuiying Hu, Guoqing Du, Wenwei Lin, Lie Li, Shashank Bharill, Rachel A. Ness, Adrian Stecuła, Steven M. Offer, Robert B. Diasio, Anne T. Nies, Matthias Schwab, Guido Cavaletti, Eberhard Schlatter, Giuliano Ciarimboli, Jan H.M. Schellens, Ehud Y. Isacoff, Andrej Šali, Taosheng Chen, Sharyn D. Baker, Alex Sparreboom, Navjotsingh Pabla
I whakaputaina 2016Artigo -
14
Role for Msh5 in the regulation of Ig class switch recombination mā Hideharu Sekine, Ricardo C. Ferreira, Qiang Pan‐Hammarström, Robert Graham, Beth Ziemba, Sandra S. de Vries, Jiabin Liu, Keli L. Hippen, Thearith Koeuth, Ward Ortmann, Akiko Iwahori, Margaret K. Elliott, Steven M. Offer, Cara Skon-Hegg, Likun Du, Jill Novitzke, Annette T. Lee, Nianxi Zhao, Joshua D. Tompkins, David Altshuler, Peter K. Gregersen, Charlotte Cunningham‐Rundles, Reuben S. Harris, Chengtao Her, David L. Nelson, Lennart Hammarström, Gary S. Gilkeson, Timothy W. Behrens
I whakaputaina 2007Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Gene
Genetics
Fluorouracil
Genotype
Pharmacogenetics
Biochemistry
DPYD
Dihydropyrimidine dehydrogenase
Thymidylate synthase
Chemotherapy
Enzyme
Pharmacology
Medicine
Chemistry
Internal medicine
Oncology
Cell biology
Computational biology
DNA
Enzyme assay
Antibody
Cancer
Catabolism
Computer science
Toxicity
Uracil
Activation-induced (cytidine) deaminase
Adverse effect
African american